Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05630053 · ClinicalTrials.gov registry record · NA

Cemented vs Cementless Persona Keel RCT

A NA study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.

Active
Registry status
NA
Development phase
300
Enrollment target
8
Study locations

NCT05630053 is a NA study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 300 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05630053, a NA study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
8
Study locations

Study Summary

The main objective of this study is to evaluate the safety, performance, and clinical benefits of the Persona Keel cementless and cemented knee.

Interventions

  • DEVICE Cementless Persona Knee System
  • DEVICE Cemented Persona Knee System

Study Locations (8)

Pennsylvania

  • Rothman Institute - Bryn Mawr
  • Lehigh Valley Hospital - Dickson City - Dickson City

Colorado

  • Centura Health - Westminster

Illinois

  • Northwestern University - Chicago

Maryland

  • Johns Hopkins University - Baltimore

Oregon

  • Oregon Health & Science University - Portland

Texas

  • Houston Methodist Hospital - Houston

Virginia

  • Anderson Orthopaedic Research Institute - Alexandria

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-07-25
Est. Completion 2032-12
Phase NA

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT05630053

The ClinicalTrials.gov registry entry for NCT05630053 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (94% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Cementless Persona Knee System is the first listed.

NCT05630053 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Pennsylvania, Colorado, Illinois.

Frequently Asked Questions

What is clinical trial NCT05630053 about?

NCT05630053 is a clinical study titled "Cemented vs Cementless Persona Keel RCT". The main objective of this study is to evaluate the safety, performance, and clinical benefits of the Persona Keel cementless and cemented knee.

What is the current status of trial NCT05630053?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-07-25. Estimated completion is 2032-12.

What conditions does trial NCT05630053 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis, Knee Pain Chronic, Traumatic Arthritis.

What interventions are being tested in trial NCT05630053?

The interventions under investigation include: Cementless Persona Knee System (DEVICE), Cemented Persona Knee System (DEVICE).

Who is sponsoring clinical trial NCT05630053?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05630053 being conducted?

This trial has 8 study locations across Colorado, Illinois, Maryland, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.